Drug intelligence / Profile preview

hydrocortisone acetate

Development stage
Approved
Lead developer
Stiefel
Modality
Small Molecules
Administration
Topical
01

Overview

HC45 Cream is a topical corticosteroid product containing the active ingredient **hydrocortisone acetate** at a concentration of 1.0% w/w. It is primarily indicated for the treatment of mild to moderate atopic eczema, allergic and irritant contact dermatitis, insect bite reactions, and other minor inflammatory skin conditions. The drug acts by binding to and activating the **glucocorticoid receptor**, which modulates gene expression to suppress the production of pro-inflammatory cytokines and mediators, thereby reducing redness, itching, and swelling. Originally developed by **Stiefel Laboratories** (now a subsidiary of **GSK**), HC45 Cream is available over-the-counter in the United Kingdom and has been utilized as an active comparator in clinical trials evaluating novel therapies for atopic dermatitis.

Brand names
HC45 CreamHC-45 CreamHC 45 CreamHC45HC-45HC 45
Other names
hydrocortisone acetate 1% cream
02

Targets

GR (Glucocorticoid receptor)ANXA1 (Annexin A1)HSD11B2 (11β-HSD2)3β-HSD (3β-Hydroxysteroid Dehydrogenase/Δ5-4 isomerase type 1)

Beyond the preview

Go deeper on hydrocortisone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call